Lifeng Fu
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
-
- Computational Drug Discovery Methods
Papers in
- Epidemiology 10
- Influenza Virus Research Studies 7
- Respiratory viral infections research 5
- Co-authors
- Jianxun Qi (10 shared papers)George F. Gao (10 shared papers)Yi Shi (4 shared papers)Xuebing Li (6 shared papers)Yan Wu (4 shared papers)Gary Wong (2 shared papers)Hao Song (3 shared papers)Weili Kong (2 shared papers)
- Journals
- Frontiers in Bioengineering and Biotechnology (3 papers)Journal of Virology (3 papers)Journal of Medicinal Chemistry (2 papers)Drug Delivery (2 papers)Molecular Genetics and Genomics (1 paper)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Lifeng Fu
36 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Infectious Diseases 437
- Computational Theory and Mathematics 283
- Molecular Biology 447
- Pharmacology 44
- Animal Science and Zoology 51
Countries citing papers authored by Lifeng Fu
This map shows the geographic impact of Lifeng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifeng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifeng Fu more than expected).
Fields of papers citing papers by Lifeng Fu
This network shows the impact of papers produced by Lifeng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifeng Fu. The network helps show where Lifeng Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lifeng Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease Hit paper breakdown → | 2020 | 392 |
| 2 | 2016 | 187 | |
| 3 | 2005 | 78 | |
| 4 | 2021 | 73 | |
| 5 | 2019 | 34 | |
| 6 | 2015 | 34 | |
| 7 | 2007 | 29 | |
| 8 | 2016 | 29 | |
| 9 | 2021 | 25 | |
| 10 | 2024 | 23 | |
| 11 | 2016 | 23 | |
| 12 | 2003 | 21 | |
| 13 | 2021 | 18 | |
| 14 | 2022 | 15 | |
| 15 | 2022 | 15 | |
| 16 | 2019 | 14 | |
| 17 | 2022 | 13 | |
| 18 | 2006 | 13 | |
| 19 | 2021 | 12 | |
| 20 | 2013 | 12 |
About Lifeng Fu
Lifeng Fu is a scholar working on Epidemiology, Molecular Biology, Infectious Diseases, Computational Theory and Mathematics and Biomedical Engineering, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (7 papers), Computational Drug Discovery Methods (6 papers), Respiratory viral infections research (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Viral gastroenteritis research and epidemiology (4 papers), Pharmacological Effects of Natural Compounds (4 papers), Bone Tissue Engineering Materials (3 papers) and Animal Virus Infections Studies (2 papers). The work is most often cited by research in Infectious Diseases (437 citations), Computational Theory and Mathematics (283 citations), Molecular Biology (447 citations), Pharmacology (44 citations) and Animal Science and Zoology (51 citations). Lifeng Fu has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Jianxun Qi, George F. Gao, Yi Shi, Xuebing Li, Yan Wu, Gary Wong, Hao Song, Weili Kong, Quan‐Hong Yao and Zhenjun Li. Their work appears in journals such as Frontiers in Bioengineering and Biotechnology, Journal of Virology, Journal of Medicinal Chemistry, Drug Delivery and Molecular Genetics and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.